Use of the case-crossover design to study prolonged drug exposures and insidious outcomes

Annals of Epidemiology

Volumn 14, Issue 4, 2004, Pages 296-303

  Wang, Philip S ^a   Schneeweiss, Sebastian ^a   Glynn, Robert J ^a   Mogun, Helen ^a   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Case crossover Design; Central nervous system; Central Nervous System Dysfunction; CI; CNS; Confidence interval; New Jersey; NJ; PAAD; Pharmaceutical Assistance to the Aged and Disabled program; Prolonged Drug Exposures; Relative risk; RR

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; CORTICOSTEROID DERIVATIVE; DIGOXIN; MULTIVITAMIN; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; STATIN;

AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DELIRIUM; DRUG EXPOSURE; DRUG INDUCED DISEASE; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; METHODOLOGY; PRIORITY JOURNAL; RISK; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TOXICITY; TREATMENT OUTCOME; UNITED STATES;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DISEASES; COMORBIDITY; CROSS-OVER STUDIES; DIGOXIN; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NARCOTICS; NEW JERSEY; RISK ASSESSMENT; TIME FACTORS;

EID: 1842610849     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2003.09.012     Document Type: Article

References (38)

1. Iglehart J.K. The American health care system: expenditures. N Engl J Med. 340:1999;70-76.
2. Lessler J.T., Harris B.S.H. Medicaid Data as a Source for Postmarketing Surveillance Information, Final Report. 1984;Research Triangle Institute, Research Triangle Park, NC.
3. Fisher E.S., Whaley F.S., Krushat M., Malenka D.J., Fleming C., Baron J.A., et al. The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. Am J Public Health. 82:1992;243-248.
4. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 133:1991;144-153.
5. Mittleman M.A., Maclure M., Robins J.M. Control sampling strategies for case-crossover studies: An assessment of relative efficiency. Am J Epidemiol. 142:1995;91-98.
6. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology. 7:1996;231-239.
7. Mittleman M.A., Maclure M., Tofler G.H., Sherwood J.B., Goldberg R.J., Muller J.E., et al. Triggering of acute myocardial infarction by physical exertion: Protection against triggering by regular exertion. N Engl J Med. 329:1993;1677-1683.
8. Mittleman M.A., Maclure M., Sherwood J.B., Mulry R.P., Tofler G.H., Jacobs S.C., et al. Triggering of acute myocardial infarction by episodes of anger. Circulation. 92:1995;1720-1725.
9. Muller J.E., Mittleman M.A., Maclure M., Sherwood J.B., Tofler G.H. Triggering of acute myocardial infarction by sexual activity: Low absolute risk and prevention by regular physical exertion. JAMA. 275:1996;1405-1409.
10. Mittleman M.A., Mintzer D., Maclure M., Tofler G.H., Sherwood J.B., Muller J.E. Triggering of myocardial infarction by cocaine. Circulation. 99:1999;2737-2741.
11. Redelmeier D.A., Tibshirani R.J. Association between cellular-telephone calls and motor vehicle collisions. N Engl J Med. 336:1997;453-458.
12. Suissa S. The case-time-control design. Epidemiology. 6:1995;248-253.
13. Dixon K.E. A comparison of case-crossover and case-control designs in a study of risk factors for hemorrhagic fever with renal syndrome. Epidemiology. 8:1997;243-246.
14. Schneeweiss S., Sturmer T., Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 6:(suppl. 3):1997;S51-S59.
15. Conn D.K. Neuropsychiatric syndromes in the elderly: An overview. Conn D.K., Grek A., Sadavoy J. Psychiatric Consequences of Brain Disease in the Elderly. 1989;193-208 Plenum, New York.
16. Chisolm S.E., Deniston L.O., Igrisan R.M., Barbus A.J. Prevalence of confusion in elderly hospitalized patients. J Gerontol Nurs. 8:1982;87-96.
17. Cole M.G., Primeau F.J. Prognosis of delirium in elderly hospital patients. CMAJ. 149:1993;41-46.
18. Rockwood K. The occurrence and duration of symptoms in elderly patients with delirium. J Gerontol. 48:1993;M162-M166.
19. Inouye S.K., Charpentier P.A. Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationships with baseline vulnerability. JAMA. 275:1996;852-857.
20. Rockwood K. Acute confusion in elderly medical patients. J Am Geriatr Soc. 37:1989;150-154.
21. Trzepacz P.T., Teague G.B., Lipowski Z.J. Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry. 7:1985;101-106.
22. Lewis L.M., Miller D.K., Morley J.E., Nork M.J., Lasater L.C. Under-recognized delirium in ED geriatric patients. Am J Emerg Med. 13:1995;142-145.
23. Medical Economics Company. Physicians' Desk Reference. 2002;Medical Economics Company, Montvale, NJ.
24. Sawe J., Dahlstrom B., Paalzow L., Rane A. Morphine kinetics in cancer patients. Clin Pharmacol Ther. 30:1981;629-635.
25. Chan C.L.C., Matzke G.R. Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics. Drug Intell Clin Pharm. 21:1987;773-783.
26. Kreek M.J. Methadone in treatment: physiological and pharmacological issues. Dupont R.I., Goldstein A., O'Donnell J. Handbook on Drug Abuse. 1979;57-86 US Govt. Printing Office, Washington, DC.
27. Kaiko R.F., Wallenstein S.L., Rogers A.F., Grabinski P.Y., Houde R.W. Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med. 304:1981;1501-1505.
28. rd ed. 1996;281-292 Springer-Verlag, New York.
29. nd ed:1996;479-495 American Psychiatric Association Press, Washington, DC.
30. nd ed:1996;497-528 American Psychiatric Association Press, Washington, DC.
31. St. Anthony Hospital. Physician's DRG Working Guidebook. 1986;St. Anthony Hospital, Louisville, Kentucky.
32. International Classification of Diseases. 9th Revision, Clinical Modifications. v. 1. Diseases: Tabular List. Commission on Professional and Hospital Activities. 1986;Edwards Brothers, Ann Arbor, MI.
33. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry. 156:(suppl.5):1999;1-20.
34. th ed. New York: McGraw-Hill (in press).
35. American Medical Association. Physicians' Current Procedural Terminology. 4th ed. 1989;American Medical Association, Chicago.
36. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45:1992;613-619.
37. Charlson M.E., Ales K.A., Pompei P., MacKenzie C.R. A new method of classification of prognostic comorbidity for longitudinal studies: development and validation. Journal of Chronic Diseases. 40:1987;373-383.
38. SAS Institute. SAS release 8.2. 2001;SAS Institute, Cary, NC.